Cardiology

Ramadan fasting can be safe for patients with heart failure

Ramadan fasting can be safe for patients with heart failure, according to research presented today at the 29th Annual Conference of the Saudi Heart Association (SHA29), held 1 to 3 March in Riyadh, Saudi Arabia. Experts from ...

Cardiology

Research supports pulmonary benefits for ACEIs, ARBs

(HealthDay)—Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) might play an important role in the prevention and treatment of emphysema, according to a study published in the May ...

Oncology & Cancer

Sartans improve survival, time to recurrence in liver cancer

(HealthDay)—For patients with hepatocellular carcinoma after radiofrequency ablation, angiotensin II receptor 1 blockers (sartans) correlate with significantly improved overall survival and time to recurrence, according ...

Medications

Medications can increase risk of heat-related illness

(HealthDay)—Commonly used medications may increase the risk of dehydration and heat-related illness during hot weather, according to an article published online June 13 in the Journal of Clinical Pharmacy and Therapeutics.

Diseases, Conditions, Syndromes

Combined drug treatment combats kidney disease

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Diseases, Conditions, Syndromes

Role of screening, monitoring in early kidney disease unclear

(HealthDay) -- At least one in 10 U.S. adults is estimated to have chronic kidney disease, but whether screening and monitoring people in the earlier stages of the disease provides a benefit just isn't clear, a new review ...

page 1 from 2